FDA finalizes guidance on fast-track for drug approvals | Modern Healthcare

The Food and Drug Administration has finalized a guidance (PDF) that will help drug and biologics manufacturers bring products that treat unmet needs to the market faster than the usual approval pathways currently make possible.

Click here to read more.